Department of Pharmacology and TherapeuticsCollege of Medicine, University of Florida, PO Box 100267, Gainesville, Florida 32610, USADepartment of Veterans AffairsMedical Center, Gainesville, Florida 32608-1197, USA.
Department of Pharmacology and TherapeuticsCollege of Medicine, University of Florida, PO Box 100267, Gainesville, Florida 32610, USADepartment of Veterans AffairsMedical Center, Gainesville, Florida 32608-1197, USADepartment of Pharmacology and TherapeuticsCollege of Medicine, University of Florida, PO Box 100267, Gainesville, Florida 32610, USADepartment of Veterans AffairsMedical Center, Gainesville, Florida 32608-1197, USA.
J Endocrinol. 2014 Jul;222(1):27-41. doi: 10.1530/JOE-13-0455.
The present investigation examined whether leptin stimulation of ventral tegmental area (VTA) or nucleus of the solitary tract (NTS) has a role in body weight homeostasis independent of the medial basal hypothalamus (MBH). To this end, recombinant adeno-associated viral techniques were employed to target leptin overexpression or overexpression of a dominant negative leptin mutant (leptin antagonist). Leptin antagonist overexpression in MBH or VTA increased food intake and body weight to similar extents over 14 days in rats. Simultaneous overexpression of leptin in VTA with antagonist in MBH resulted in food intake and body weight gain that were less than with control treatment but greater than with leptin alone in VTA. Notably, leptin overexpression in VTA increased P-STAT3 in MBH along with VTA, and leptin antagonist overexpression in the VTA partially attenuated P-STAT3 levels in MBH. Interestingly, leptin antagonist overexpression elevated body weight gain, but leptin overexpression in the NTS failed to modulate either food intake or body weight despite increased P-STAT3. These data suggest that leptin function in the VTA participates in the chronic regulation of food consumption and body weight in response to stimulation or blockade of VTA leptin receptors. Moreover, one component of VTA-leptin action appears to be independent of the MBH, and another component appears to be related to leptin receptor-mediated P-STAT3 activation in the MBH. Finally, leptin receptors in the NTS are necessary for normal energy homeostasis, but mostly they appear to have a permissive role. Direct leptin activation of NTS slightly increases UCP1 levels, but has little effect on food consumption or body weight.
本研究旨在探讨瘦素刺激腹侧被盖区(VTA)或孤束核(NTS)是否在不依赖于内侧基底部下丘脑(MBH)的情况下对体重平衡发挥作用。为此,采用重组腺相关病毒技术靶向瘦素过表达或显性负性瘦素突变体(瘦素拮抗剂)过表达。在大鼠中,MBH 或 VTA 中的瘦素拮抗剂过表达在 14 天内使摄食量和体重增加到相似程度。同时在 VTA 中过表达瘦素与在 MBH 中过表达拮抗剂导致摄食量和体重增加小于单独在 VTA 中用瘦素处理,但大于单独在 VTA 中用瘦素处理。值得注意的是,VTA 中的瘦素过表达增加了 MBH 以及 VTA 中的 P-STAT3,而 VTA 中的瘦素拮抗剂过表达部分降低了 MBH 中的 P-STAT3 水平。有趣的是,VTA 中的瘦素拮抗剂过表达增加了体重增加,但 NTS 中的瘦素过表达未能调节摄食量或体重,尽管 P-STAT3 增加。这些数据表明,VTA 中的瘦素功能参与了对 VTA 瘦素受体刺激或阻断的慢性食物消耗和体重调节。此外,VTA-瘦素作用的一个组成部分似乎独立于 MBH,另一个组成部分似乎与 MBH 中瘦素受体介导的 P-STAT3 激活有关。最后,NTS 中的瘦素受体对于正常的能量平衡是必要的,但它们主要表现出许可作用。瘦素对 NTS 的直接激活略微增加 UCP1 水平,但对摄食量或体重几乎没有影响。